Headline
The latest stories from AHA Today.
The Equal Employment Opportunity Commission and the Department of Justice March 19 announced the release of two documents warning against unlawful discrimination related to diversity, equity and inclusion in the workplace.
A JAMA Network Open study published March 13 found that 90% of Medicaid managed care plans cover at least one alcohol use disorder medication without prior authorization and quantity limits.
The International Hospital Federation is accepting nominations through May 2 for its 2025 awards honoring excellence in hospitals and health care organizations globally.
The Food and Drug Administration March 20 issued an alert on a potentially high-risk issue with Calyxo CVAC Aspiration Systems.
The Department of Health and Human Services yesterday announced that it renewed the public health emergency for the nation’s opioid crisis an additional 90 days.
There have been 301 confirmed cases of measles across the U.S. so far this year, surpassing the 2024 total of 285, according to the latest data from the Centers for Disease Control and Prevention.
The U.S. birth rate fell 2% in 2023 to about 3.6 million, according to final data released March 18 by the Centers for Disease Control and Prevention.
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage Embolization Devices due to reports of a higher incidence of the flexible, braided tube part of the device failing to properly attach or stay attached to the blood vessel wall…
The AHA March 18 commented on the Drug Enforcement Administration's proposed rule for special registrations for telemedicine prescribing of controlled substances.
The Food and Drug Administration March 14 released a notice on a nationwide shortage of hemodialysis tubes expected to last through early fall.